Device to deliver predetermined amount of substance to body orifice
Summary
USPTO granted Patent US12594388B2 to AptarGroup, Inc. on April 7, 2026, covering a device for delivering predetermined amounts of substances to body orifices. The invention includes a container, delivery end, valve with active/inactive configurations, trigger mechanism, and fluid-tight chamber. The patent contains 28 claims and was filed on June 7, 2022.
What changed
USPTO has issued Patent US12594388B2 to AptarGroup, Inc., covering a delivery device for administering precise amounts of substances to body orifices. The patented device features a valve system with distinct active and inactive configurations, allowing controlled substance delivery through a trigger mechanism. The invention classifies under CPC codes A61M 15/00 series (inhalers and nasal delivery devices) and B05B 11/00 series (atomizing or spraying devices).
For medical device manufacturers, this patent establishes intellectual property rights that may restrict design options for similar drug delivery devices targeting body orifices. Competitors developing products in the nasal spray, inhaler, or general orifice delivery space should conduct freedom-to-operate analyses to assess potential infringement risks and consider licensing discussions with AptarGroup if pursuing similar technologies.
What to do next
- Monitor for potential licensing inquiries from competitors
- Review product development plans for freedom-to-operate considerations
Archived snapshot
Apr 8, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Device to deliver a predetermined amount of a substance to a natural orifice of the body
Grant US12594388B2 Kind: B2 Apr 07, 2026
Assignee
AptarGroup, Inc.
Inventors
Daniel Shahaf, Iris Shichor
Abstract
A device for delivering a predetermined amount of at least one substance to a body orifice of a subject includes a) a container for containing said at least one substance; b) a delivery end for placement in proximity to the orifice, the delivery end being in fluid communication with the container; c) a valve mechanically connectable to said container, characterized by at least two configurations: (i) an ACTIVE CONFIGURATION in which said valve enables delivery of predetermined amount of said substance from said container to said body orifice via said delivery end; and, (ii) an INACTIVE CONFIGURATION, in which said valve prevents delivery of said predetermined amount of said substance from said container to said body orifice; d) a trigger mechanism adapted to reconfigure said valve from said INACTIVE CONFIGURATION to said ACTIVE CONFIGURATION, and vice versa; and e) a fluid tight chamber.
CPC Classifications
A61M 15/009 A61M 11/007 A61M 15/0048 A61M 15/0003 A61M 15/0021 A61M 15/003 A61M 15/0036 A61M 15/0041 A61M 2016/0027 A61M 2202/0225 A61M 15/0093 A61M 2205/583 A61M 15/08 A61M 2205/073 A61M 11/02 A61M 15/0025 A61M 2202/0208 A61M 2202/025 A61M 2202/0266 A61M 2202/0291 A61M 2205/3306 A61M 2205/3375 A61M 2205/581 A61M 2206/10 A61M 2209/045 A61M 2210/0618 A61M 2210/0625 A61M 2210/065 A61M 2210/0662 A61M 2210/1089 A61M 2210/1475 A61M 31/00 B05B 11/0027 B05B 11/0032 B05B 11/0054 B05B 11/061 B05B 11/062
Filing Date
2022-06-07
Application No.
17834303
Claims
28
Related changes
Get daily alerts for ChangeBridge: Patent Grants - Medical Devices (A61M)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ChangeBridge: Patent Grants - Medical Devices (A61M) publishes new changes.